Anson Funds Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Anson Funds Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.9K	Hold	42,400	–	–	﹤0.01%	172
2026 Q1	$19.5K	Hold	42,400	–	–	﹤0.01%	128
2025 Q4	$64.9K	Hold	42,400	–	–	0.01%	118
2025 Q3	$98.2K	Hold	42,400	–	–	0.01%	107
2025 Q2	$127K	Hold	42,400	–	–	0.02%	100
2025 Q1	$158K	Hold	42,400	–	–	0.03%	110
2024 Q4	$103K	Buy	+42,400	New	+$27.2K	0.01%	139

Other funds holding MDCXW

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Anson Funds Management's MDCXW Position: Q2 2026 in Review

Anson Funds Management held its Medicus Pharma Warrant (MDCXW) position steady in Q2 2026 at 42,400 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #172.

Anson Funds Management first reported a position in MDCXW in Q4 2024 and has held it in 7 quarters since. The position peaked at $158K in Q1 2025. 4 funds tracked by Wall St. Rank hold MDCXW as of Q2 2026.

Anson Funds Management held 42,400 shares of Medicus Pharma Warrant worth $18.9K as of Q2 2026.
Anson Funds Management left its Medicus Pharma Warrant share count unchanged in Q2 2026.
Medicus Pharma Warrant made up ﹤0.01% of Anson Funds Management's portfolio in Q2 2026, its #172 holding.
Anson Funds Management first reported a position in Medicus Pharma Warrant in Q4 2024 and has held it in 7 quarters since.
Anson Funds Management's Medicus Pharma Warrant position peaked at $158K in Q1 2025.
4 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q2 2026.

Based on Anson Funds Management's 13F filing for Q2 2026, filed 13 Aug 2026.